This analysis showed that DFNA5 expression was higher in kidney cancer, lymphoma, pancreatic cancer, cervical cancer, head and neck cancer, melanoma, and sarcoma than in normal tissues (Fig. 1A). This evidence concerns the gene GSDME and familial pancreatic carcinoma.